First Turn Management »

Arcus Biosciences Incorporated shares owned by First Turn Management

Quarter-by-quarter ownership of Arcus Biosciences Incorporated (RCUS) shares owned by First Turn Management from 13F filings

Historical chart of First Turn Management investment in Arcus Biosciences Incorporated

Tip: Access up to 7 years of quarterly data

All positions including Arcus Biosciences Incorporated held by First Turn Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Arcus Biosciences Incorporated by First Turn Management

Quarter filed Position value Share count Share price at filing
2025-12-31 $14M 565k 23.83

More positions owned by First Turn Management

Abivax Sa Sponsored Ads (ABVX)
Revolution Medicines (RVMD)
Insmed Com Par $.01 (INSM)
Bridgebio Pharma (BBIO)
Mirum Pharmaceuticals (MIRM)
Axsome Therapeutics (AXSM)
Nuvalent Inc-a (NUVL)
Xenon Pharmaceuticals (XENE)
Apogee Therapeutics (APGE)
Terns Pharmaceuticals (TERN)
Newamsterdam Pharma Company Ordinary Shares (NAMS)
United Therapeutics Corporation (UTHR)
Vera Therapeutics Cl A (VERA)
Cogent Biosciences (COGT)
Ascendis Pharma A/s Sponsored Adr (ASND)

View all positions for First Turn Management

Top funds holding Arcus Biosciences Incorporated

Gilead Sciences
BlackRock
Vanguard Group
Suvretta Capital Management
State Street Corporation
Woodline Partners
Marshall Wace
Point72 Asset Management
Siren
FMR
Fisher Investments
Caption Management
Geode Capital Management
Balyasny Asset Management
Bnp Paribas Investment Partners

View all funds holding Arcus Biosciences Incorporated